ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
229.94
-22.89 (-9.05%)
At close: Oct 30, 2026, 4:00 PM EDT
230.00
+0.06 (0.03%)
After-hours: Oct 30, 2026, 7:56 PM EDT

ResMed Cash Flow Statement

Millions USD. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Income
1,5931,5231,4011,021897.56779.44
Depreciation & Amortization
219.2218.64210.34188.76172.51158.3
Other Amortization
19.1125.5125.4727.4525.0635.55
Asset Writedown & Restructuring Costs
6.24--33.249.18-
Loss (Gain) From Sale of Investments
-1.2510.6610.34.05-9.9212.2
Loss (Gain) on Equity Investments
-2.78-2.38-3.641.8510.148.49
Stock-Based Compensation
112.66104.3591.6680.1871.1465.26
Other Operating Activities
-----20.23-
Change in Accounts Receivable
-61.91-96.78-76.68-134.28-106.5119.35
Change in Inventory
-67.02-9.92-80.17172.2-248.83-311.68
Change in Accounts Payable
227.84172.7290.96122.0731.34-247.63
Change in Other Net Operating Assets
-212.56-140.2682.63-115.21-138.13-168.11
Operating Cash Flow
1,7711,8061,7521,401693.3351.15
Operating Cash Flow Growth
-5.97%3.10%25.00%102.11%97.44%-52.34%

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Capital Expenditures
-162.06-156.29-89.87-99.46-119.67-134.84
Cash Acquisitions
-357.69-350.72-139.25-133.46-1,013-42.78
Sale (Purchase) of Intangibles
-20.51-20.89-10.78-15.4-14.33-21.2
Investment in Securities
-26.33-25.78-1.79-11.77-28.29-13.92
Other Investing Activities
15.28.4841.63-9.715.2-17.18
Investing Cash Flow
-100.57-545.2-200.05-269.78-1,160-229.92

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Long-Term Debt Issued
---1051,070288
Long-Term Debt Repaid
--10-40-835-405-166
Net Debt Issued (Repaid)
-260-10-40-730665122
Issuance of Common Stock
69.9574.574.4453.0949.1447.38
Repurchase of Common Stock
-1,508-721.87-318.1-158.77-30.63-52.41
Common Dividends Paid
-356.87-349.66-310.88-282.32-258.28-245.34
Other Financing Activities
---11.71-1.29-2.36-
Financing Cash Flow
-2,055-1,007-606.25-1,119422.87-128.36

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Foreign Exchange Rate Adjustments
11.296.1825.8-1.72-2.15-14.43
Net Cash Flow
-373.11259.78971.0910.47-45.82-21.57

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
1,6091,6501,6621,302573.63216.31
Free Cash Flow Growth
-9.02%-0.73%27.65%126.94%165.19%-65.88%
Free Cash Flow Margin
28.07%29.18%32.29%27.79%13.58%6.04%
Free Cash Flow Per Share
11.0811.2911.288.823.891.47
Levered Free Cash Flow
1,298939.251,2081,185400.59127.68
Unlevered Free Cash Flow
1,298939.251,2081,216432.55141.63

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash Interest Paid
24.7827.0628.4245.7147.3822.31
Cash Income Tax Paid
367.15357.17214.01278.4216.87478.12
Change in Working Capital
-113.65-74.2416.7444.78-462.13-708.08
SEC Filings: 10-K · 10-Q